AbCellera Biologics, Inc. (ABCL)
5.20
+0.06
(+1.17%)
USD |
NASDAQ |
May 22, 16:00
5.26
+0.06
(+1.15%)
After-Hours: 20:00
AbCellera Biologics Profit Margin (Quarterly) : -519.1% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tempus AI, Inc. | -36.17% |
| Standard BioTools, Inc. | -69.17% |
| Cytek Biosciences, Inc. | -42.75% |
| Agilent Technologies, Inc. | 16.96% |
| Inotiv, Inc. | -27.60% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.69% |
| Return on Assets | -10.64% |
| Return on Invested Capital | -13.00% |
| Gross Profit Margin (Quarterly) | -4.09% |
| Operating Margin (Quarterly) | -691.7% |
| Return on Net Operating Assets | -26.43% |